small molecule

ACTHAR GEL

CORTICOTROPIN

Loss of exclusivityJuly 2041latest FDA-listed patent expiry
CompanyMALLINCKRODT PHARMACEUTICALS IRELAND LTD

Drug detail

Brand nameACTHAR GEL
Active ingredientCORTICOTROPIN
Strength80 UNITS/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
Marketing statusRX

Listed patents

PatentExpiresType
11752199July 2041use U-3688

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

ACTHAR GEL patent cliff — loss of exclusivity July 2041 | CliffBio